C. Boyd Clarke

Executive Chairman at FluGen, Inc.

C. Boyd Clarke

C. Boyd Clarke

Executive Chairman at FluGen, Inc.

Overview

Career Highlights

Pasteur Merieux MSD Ltd.
FluGen, Inc.
LigoCyte Pharmaceuticals, Inc.

RelSci Relationships

730

Number of Boards

13

Birthday

1950

Age

71

Contact Data

Trying to get in touch with C. Boyd Clarke? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!

Relationships

View Relationship Details

RelSci Relationships are individuals C. Boyd Clarke likely has professional access to. A relationship does not necessarily indicate a personal connection.

David J. Clark

Chief Medical Officer at Allena Pharmaceuticals, Inc.

Relationship likelihood: Strong

Paul V. Radspinner

Founder at FluGen, Inc.

Relationship likelihood: Strong

Alan C. Mendelson

General Counsel & Secretary at Optivia Biotechnology, Inc.

Relationship likelihood: Strong

Bruce Carter

Former Executive Chairman at Infectious Disease Research Institute

Relationship likelihood: Strong

Todd Brady

Chief Executive Officer, President & Director at Aldeyra Therapeutics, Inc.

Relationship likelihood: Strong

Ian Massey

Former President, Chief Executive Officer & Director at StemCells, Inc.

Relationship likelihood: Strong

Gabriele Neumann

Director & Co-Founder at FluGen, Inc.

Relationship likelihood: Strong

Dan T. Stinchcomb

Chief Scientific Officer at Infectious Disease Research Institute

Relationship likelihood: Strong

Gary Phillips

Former Executive Chairman at Envisia Therapeutics, Inc.

Relationship likelihood: Strong

Robert Lee Butchofsky

Founder at Mati Therapeutics, Inc.

Relationship likelihood: Strong

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.

In The News

CNBC

January 26, 2018

Scientists are now rushing to develop a universal flu vaccine

CNBC

January 9, 2018

Get ready, the worst flu season in history may be coming

Business Wire

September 19, 2017

FluGen Announces Expanded Role for Clinical Advisory Board: Dr. Robert Belshe to Chair

Business Wire

September 5, 2017

FluGen Announces C. Boyd Clarke Has Been Named Executive Chairman

Milwaukee Journal Sentinel (Wisconsin)

August 10, 2017

FluGen plans trials of universal flu vaccine

Paths to C. Boyd Clarke

Potential Connections via
Relationship Science

You

C. Boyd Clarke

Executive Chairman at FluGen, Inc.

Education

Master of Arts in History

University of Calgary

The University of Calgary (or UCalgary) is a public research university located in Calgary, Alberta, Canada. Founded in 1966 (after operating as the Calgary branch of the University of Alberta since 1945) the University of Calgary is composed of 14 faculties and more than 85 research institutes and centres.

Career History

Executive Chairman

Current

FluGen, Inc.

Flugen, Inc. develops and produces influenza vaccines. Its products include a live attenuated vaccine candidate, a cell-line technology that provides vaccine production efficiency and capacity, and a novel, vaccine-loaded intradermal delivery technology.The company was founded by Yoshihiro Kawaoka, Gabriele Neumann and Paul Radspinner in 2007 and is headquartered in Madison, WI.

Venture Advisor

2007 - Prior

ProQuest Management LLC

ProQuest Management invests in healthcare companies located in the US. The sectors in which they invest include biotech and pharmaceutical companies. The firm provides financing for seed to late-stage capital requirements and the firm invests in both public & private companies.

President & Chief Executive Officer

2002 - 2007

Neose Technologies, Inc.

The Group's principal activity is to develop proprietary drugs, focusing primarily on therapeutic proteins. Its technologies to develop proprietary versions of protein drugs with proven safety and efficacy and to improve the therapeutic profiles of proteins being developed. Its proprietary drug development portfolio currently consists of two therapeutic protein candidates.GlycoPEG-EPO (NE-180) is a long-acting version of erythropoietin (EPO) produced in insect cells. EPO is prescribed to stimulate production of red blood cells, and it gives treatment of chemotherapy-induced anemia and anemia associated with chronic renal failure. Its second proprietary protein, GlycoPEG-GCSF, is a long-acting version of granulocyte colony stimulating factor G-CSF and it is prescribed to stimulate production of neutrophils (a type of white blood cell). Its trademarks are NEOSE, GlycoPEGylation and GlycoConjugation. It operates predominantly in the domestic market.

Boards & Committees

Chairman

2003 - 2012

QLT, Inc.

QLT is a biotechnology company dedicated to the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. We are focused on developing our synthetic retinoid program for the treatment of certain inherited retinal diseases. QLT's head office is based in Vancouver, Canada and the company is publicly traded on NASDAQ (symbol: QLTI) and the Toronto Stock Exchange (symbol: QLT).

Chairman

Prior

MedImmune Vaccines, Inc.

MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company is located in Mountain View, CA

Director

Prior

Biotechnology Innovation Organization

Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers.

Political Donations

$2,000

2003

Biotechnology Industry Organization Political Action Committee

$250

1994

Merck & Co, Inc Political Action Committee

$250

1992

Merck & Co, Inc Political Action Committee

Transactions

Details Hidden

LigoCyte Pharmaceuticals, Inc. raised money in a private placement transaction

Investments

Details Hidden

Aldeyra Therapeutics, Inc.

Aldeyra Therapeutics, Inc. operates as a biotechnology company. It primarily focuses on the development of new products for immune-mediated, inflammatory, orphan and other diseases that are thought to be caused in part by naturally occurring toxic chemical species known as free aldehydes. The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA.

Other Affiliations

C. Boyd Clarke is affiliated with FluGen, Inc., ProQuest Management LLC, Neose Technologies, Inc., MedImmune Vaccines, Inc., US Bioscience, Inc., Merck & Co., Inc., LigoCyte Pharmaceuticals, Inc., Pasteur Merieux MSD Ltd., QLT, Inc., MedImmune Vaccines, Inc., Biotechnology Innovation Organization

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by C. Boyd Clarke. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of C. Boyd Clarke's profile does not indicate a business or promotional relationship of any kind between RelSci and C. Boyd Clarke.